AU2021204839A1 - Telomerase Moderator - Google Patents

Telomerase Moderator Download PDF

Info

Publication number
AU2021204839A1
AU2021204839A1 AU2021204839A AU2021204839A AU2021204839A1 AU 2021204839 A1 AU2021204839 A1 AU 2021204839A1 AU 2021204839 A AU2021204839 A AU 2021204839A AU 2021204839 A AU2021204839 A AU 2021204839A AU 2021204839 A1 AU2021204839 A1 AU 2021204839A1
Authority
AU
Australia
Prior art keywords
telomerase
toad
modifier
cancer
moderator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021204839A
Inventor
qingli yin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yin Yiming
Original Assignee
Yin Yiming
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yin Yiming filed Critical Yin Yiming
Priority to AU2021204839A priority Critical patent/AU2021204839A1/en
Publication of AU2021204839A1 publication Critical patent/AU2021204839A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/65Amphibians, e.g. toads, frogs, salamanders or newts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L13/00Meat products; Meat meal; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L23/00Soups; Sauces; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention is directed to a telomerase modifier extracted from the muscle of toads. The telomerase modifier is useful for the treatment of cancer.

Description

Telomerase Moderator
The research of life sciences has been over a hundred years. And genetic science, that is, the identification of Shuang Luo Xuan DNA research, has also been nearly 70 years old. The development of modern medicine is progressing in the direction of precision medicine. The "telomerase modifier" of the present invention can advance the treatment of cancer tumors by a big step. Reached the level of precision medicine. It can also be said that the problem of treating cancer tumors is fundamentally solved! You can put an end to cancer tumors just like using "Vaccinia" to eliminate "smallpox". Since 1997, "telomere and telomerase" was confirmed, three scientists have won the Nobel Prize in 2009 for this. In continuing research, scientists have found that too strong or too weak telomerase will cause the uncontrolled cell replication and the formation of cancer tumors. Therefore, in the past 24 years, many scientists have been searching for drugs and methods to restore telomerase back to normal. (You can refer to the lecture by Professor Deng Shuchen of National Taiwan University, "Telomere and Telomerase". His tutor for overseas studies happened to be the three Nobel Prize-winning scientists). Fortunately, we were the first to find this miraculous cancer medicine! It is efficient, inexpensive, convenient, fast, simple and so on. And can treat all kinds of cancer tumors at the same time! In this way, we are tantamount to solving the precision treatment problems in the two major medical fields. This "telomerase modifier" exists in the muscles of toads. Although toads have been used as medicine in China for two thousand years, there has never been a record of using toad muscles alone. Therefore, the present invention should be the first. Judging from the many cases of cancer and tumors we have cured, he should have prevented the excessive and low levels of telomerase. Return uncontrolled cell division to normal. He is definitely not killing cancer cells, because then, a large amount of foreign protein will enter the blood. And trigger a dangerous hyperthermia, that is, a cytokine storm. He is neither pain nor itching, so that the patient has no pain. He was able to cure several cancer tumors at the same time. This shows that he treats the root of the disease, not the focus. Therefore, I determined that the toad muscle used in the present invention contains a "telomerase modifier" that adjusts telomerase to be too high or low to return to normal. Put an end to cancer! The invention has epoch-making significance!
Manufacturing of telomerase modifier 1. When choosing toad species, choose species that are less toxic in their muscles. 2. Butcher, remove the head, peel, remove the internal organs, and wash. 3. Taking it, you can replace it with toad meat before accurately studying the molecular formula of the "telomerase modifier". Because the "telomerase balancer" is included. 4. Dosage: 100 grams of fresh toad meat per day for adults, simmered on low heat, eat the meat twice in the morning and evening and drink the soup. 5. In the laboratory, study the chemical molecular equation of the "telomerase modifier" and the method of artificial synthesis. 6. Research the best solution to maximize its efficiency. 7. The manufactured products of the telomerase concoction agent can be packaged in solid powder form or in canned form.
Rights of Claims
1. Modern precision medicine recognizes that the duplication and aging of human cells are controlled by the telomeres and telomerase of the chromosomes of genes (DNA). If telomerase is too strong or too weak, it will cause the loss of control of cell replication and cause tumors. In the 24 years since telomerase was confirmed in 1997, many scientists have been seeking ways to regulate telomerase. It's an honour! We were the first to discover the "telomerase modifier" that can restore telomerase to normal, thus curing many types of cancer tumors! He exists in the muscle tissue of the toad. Although toad has been used as medicine in China for two thousand years, it is our first initiative to use toad muscle tissue to treat various cancer tumors. Moreover, the present invention patent will solve problems in the two major precision medical fields.
2. How to make and take the telomerase concoction agent. Decapitate the toad, peel it off, remove its internal organs, and wash it. Get naked toads. Take 100 grams (up to 120 grams) of naked toad, put it in a pot, add appropriate amount of water, simmer over low heat, and serve twice in the morning and evening. Eat meat and soup.
3. For convenience, it can be made into canned food or dry powder. Vacuum stew can also be used to lower the boiling point. To protect the active ingredients. UV disinfection can also be used to ensure that there is no bacteria and no pests.
4. Research the chemical molecular equations of effective substances and artificially synthesize them to industrialize them.
AU2021204839A 2021-07-11 2021-07-11 Telomerase Moderator Abandoned AU2021204839A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2021204839A AU2021204839A1 (en) 2021-07-11 2021-07-11 Telomerase Moderator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2021204839A AU2021204839A1 (en) 2021-07-11 2021-07-11 Telomerase Moderator

Publications (1)

Publication Number Publication Date
AU2021204839A1 true AU2021204839A1 (en) 2022-08-18

Family

ID=82802423

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021204839A Abandoned AU2021204839A1 (en) 2021-07-11 2021-07-11 Telomerase Moderator

Country Status (1)

Country Link
AU (1) AU2021204839A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN87100876A (en) * 1987-02-03 1988-09-14 郭世杰 The method for preparing cancer therapy drug with toad
CN1205227A (en) * 1998-07-24 1999-01-20 殷作磊 Toad-mussel tumour powder and its prodn. method
CN103536628A (en) * 2013-06-28 2014-01-29 王秀丽 Toad spermine
AU2021102411A4 (en) * 2021-05-08 2021-06-24 YIN, Qingli MR Telomerase Balancer

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN87100876A (en) * 1987-02-03 1988-09-14 郭世杰 The method for preparing cancer therapy drug with toad
CN1205227A (en) * 1998-07-24 1999-01-20 殷作磊 Toad-mussel tumour powder and its prodn. method
CN103536628A (en) * 2013-06-28 2014-01-29 王秀丽 Toad spermine
AU2021102411A4 (en) * 2021-05-08 2021-06-24 YIN, Qingli MR Telomerase Balancer

Similar Documents

Publication Publication Date Title
AU2021102411A4 (en) Telomerase Balancer
CN105017438A (en) Divaricate velvetplant root and rhizome polysaccharide and application thereof in preparing medicine and functional food for immune adjustment and tumor resistance
AU2021204839A1 (en) Telomerase Moderator
KR20130022748A (en) Manufacturing method of acupuncture equipment disguised as bee venom and bee sting
CN103301161B (en) The method of Chinese medicine preparation and the application of this Chinese medicine preparation is prepared with Eupolyphaga seu steleophaga extract
ES2337537A1 (en) Food preparation and pharmaceutical composition containing an embryonic extract
Vicas et al. Chick Embryo Genotoxicity Analysis of the Green Medicine, Emblica officinalis Aqueous Extract, and Its Action on Endodontic Pathogens
CN104352826B (en) Membranous milkvetch stem and leaf is the herbal medicine and preparation method of main ingredient
CN108635540A (en) A kind of Chinese medicine ointment and preparation method thereof for treating skin eczema
CN103816443B (en) A kind of preparation method of algae health powder for dipping feet
Gostyukhina et al. Stimulation of burn wound healing in rats by nanosecond repetitive pulsed microwave radiation
CN1094366C (en) Ointment for treating burn and scald and its preparing process
CN108066518A (en) A kind of dog Chinese medicine bath lotion composition and preparation method thereof
CN102764208A (en) Formula and preparation method of anti-dandruff itching-relieving shampoo
KR20190044734A (en) Composition for treating high blood pressure
CN101103998B (en) External-applied medicinal powder for burn and scald and preparation method thereof
CN108096541A (en) A kind of medicinal liquor for treating Breast Nodules and preparation method thereof and application method
CN109289002B (en) Medicinal and edible composition
CN105495430A (en) Composition for enhancing immunity
CN1139567A (en) Chinese proprietary medicine for protrusion of intervertebral disc
Torosian et al. Inhibition of tumor metastasis by a circulating suppressor factor
CN106266473A (en) A kind of green Bulbus Allii extract with antihepatocarcinoma effect and Preparation method and use
Miller Chlorophyll for Healing
CN106266494A (en) A kind of Traditional Chinese medicine disinfectant
CN1679637A (en) Biological medicine for treating diseases from infection viral and bacterial

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted